{"id":"https://openalex.org/W2600414740","doi":"https://doi.org/10.1200/jco.2006.24.18_suppl.2557","title":"Activation of human peripheral blood immune cells in vitro by sodium stibogluconate (SSG) and SSG/IL-2 combination","display_name":"Activation of human peripheral blood immune cells in vitro by sodium stibogluconate (SSG) and SSG/IL-2 combination","publication_year":2006,"publication_date":"2006-06-20","ids":{"openalex":"https://openalex.org/W2600414740","doi":"https://doi.org/10.1200/jco.2006.24.18_suppl.2557","mag":"2600414740"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2006.24.18_suppl.2557","doi":"https://doi.org/10.1200/jco.2006.24.18_suppl.2557","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2006.24.18_suppl.2557","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111287962","display_name":"T Yi","orcid":"https://orcid.org/0000-0002-3295-025X","observed_orcids":["https://orcid.org/0000-0002-3295-025X"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"T. Yi","raw_affiliation_strings":["Cleveland Clinic Foundation, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cleveland Clinic Foundation, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027881172","display_name":"Keke Fan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K. Fan","raw_affiliation_strings":["Cleveland Clinic Foundation, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cleveland Clinic Foundation, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066748171","display_name":"James Harold Finke","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Finke","raw_affiliation_strings":["Cleveland Clinic Foundation, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cleveland Clinic Foundation, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112418138","display_name":"Ronald M. Bukowski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. Bukowski","raw_affiliation_strings":["Cleveland Clinic Foundation, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cleveland Clinic Foundation, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112252438","display_name":"Ernest C. Borden","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E. C. Borden","raw_affiliation_strings":["Cleveland Clinic Foundation, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cleveland Clinic Foundation, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1316902750"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"24","issue":"18_suppl","first_page":"2557","last_page":"2557"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":0.9735999703407288,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":0.9735999703407288,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.017500000074505806,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0031999999191612005,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sodium-stibogluconate","display_name":"sodium stibogluconate","score":0.9850000143051147},{"id":"https://openalex.org/keywords/interleukin-2","display_name":"interleukin-2","score":0.6790000200271606},{"id":"https://openalex.org/keywords/immune-cell-activation","display_name":"immune cell activation","score":0.7139999866485596},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.699999988079071},{"id":"https://openalex.org/keywords/th1-cells","display_name":"Th1 cells","score":0.777999997138977},{"id":"https://openalex.org/keywords/th2-cells","display_name":"Th2 cells","score":0.7269999980926514},{"id":"https://openalex.org/keywords/cd69","display_name":"CD69","score":0.6520000100135803},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.6729999780654907},{"id":"https://openalex.org/keywords/shp-1","display_name":"SHP-1","score":0.7099999785423279},{"id":"https://openalex.org/keywords/shp2","display_name":"SHP2","score":0.9779999852180481},{"id":"https://openalex.org/keywords/protein-tyrosine-phosphatase-inhibition","display_name":"protein tyrosine phosphatase inhibition","score":0.8939999938011169},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.5960000157356262},{"id":"https://openalex.org/keywords/cd4-t-cells","display_name":"CD4+ T cells","score":0.6940000057220459},{"id":"https://openalex.org/keywords/cd8-t-cells","display_name":"CD8+ T cells","score":0.9980000257492065},{"id":"https://openalex.org/keywords/peripheral-blood-lymphocytes","display_name":"peripheral blood lymphocytes","score":0.6629999876022339},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.5920000076293945}],"concepts":[{"id":"https://openalex.org/C2779053233","wikidata":"https://www.wikidata.org/wiki/Q731235","display_name":"ELISPOT","level":4,"score":0.8609726428985596},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7543435096740723},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5672643780708313},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.512479305267334},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.48606231808662415},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3697056770324707},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.29932016134262085},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.14573201537132263},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2006.24.18_suppl.2557","doi":"https://doi.org/10.1200/jco.2006.24.18_suppl.2557","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2006.24.18_suppl.2557","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1996394857","https://openalex.org/W2073403199","https://openalex.org/W2048076152","https://openalex.org/W2112229251","https://openalex.org/W2127697177","https://openalex.org/W2015022034","https://openalex.org/W1667574047","https://openalex.org/W2142655598","https://openalex.org/W2071922820","https://openalex.org/W2302362580"],"abstract_inverted_index":{"2557":[0],"Background:":[1],"SSG,":[2,256],"an":[3,29,146],"inhibitor":[4],"of":[5,19,40,65,89,101,139,176,191,263,278,296,303,307],"SHP-1":[6],"and":[7,67,78,84,92,186,218,234,237,250,280],"SHP2":[8],"which":[9],"are":[10],"negative":[11,308],"regulatory":[12,309],"signaling":[13,310],"tyrosine":[14],"phosphatases,":[15],"suppressed":[16],"the":[17,117,169,192,196,211,226,232,242,290],"growth":[18],"murine":[20],"renal":[21],"carcinoma":[22],"(Renca)":[23],"in":[24,58,72,114,158,173,199,203,210,231,246,269,275,287],"combination":[25,59,159,194,227],"with":[26,60,74,107,160,267],"IL-2":[27,134,161,268,304],"via":[28],"interferon":[30],"(IFN)-\u03b3+":[31],"T":[32],"cell-dependent":[33],"mechanism":[34],"(J":[35],"Immunol":[36],"175:7003\u20138,":[37],"2005).":[38],"Activation":[39],"primary":[41],"human":[42],"immune":[43,273],"cells":[44,106,164,179,202,230,274],"by":[45,98,121,133,168,180,207],"SSG":[46,55,75,122,144],"or":[47,76,132,157,172],"SSG/IL-2":[48,77,112,181,193],"would":[49],"provide":[50,284],"additional":[51],"supporting":[52],"evidence":[53],"for":[54,87,261,294,300],"clinical":[56,298],"evaluation":[57],"IL-2.":[61],"Methods:":[62],"Peripheral":[63],"blood":[64,103,213,277],"healthy":[66,216,279],"melanoma":[68,220,281],"donors":[69,217],"were":[70,165],"treated":[71],"vitro":[73,204,270],"then":[79],"subjected":[80],"to":[81,116,271,289,316],"ELISPOT":[82,99,208],"assays":[83,100,209],"FACS":[85,222],"analysis":[86,223],"quantification":[88],"TH1":[90],"(IFN-\u03b3+)":[91],"TH2":[93],"(IL-5+)":[94],"cells.":[95],"Results:":[96],"Characterization":[97],"peripheral":[102,177,212,276],"identified":[104],"IFN-\u03b3+":[105,178,201,229],"marked":[108],"increase":[109],"(9.1x)":[110],"following":[111],"treatment":[113,262],"contrast":[115],"modest":[118],"increases":[119],"induced":[120,167,228],"alone":[123,155],"(2.1x)":[124],"at":[125,136,145],"its":[126,137],"clinically":[127,260],"achievable":[128],"dose":[129,149],"(20":[130],"\u03bcg/ml)":[131,151],"(3.1x)":[135],"Cmax":[138],"low-dose":[140],"schedule":[141],"(30":[142],"IU/ml).":[143],"even":[147],"higher":[148],"(100":[150],"was":[152,182,205],"less":[153],"effective":[154],"(1.5x)":[156],"(7.8x).":[162],"IL-5+":[163],"not":[166],"agents":[170,198],"individually":[171],"combination.":[174],"Induction":[175],"detectable":[183],"after":[184],"4":[185],"16":[187],"h.":[188],"Increased":[189],"effectiveness":[190],"vs.":[195],"individual":[197],"inducing":[200],"detected":[206],"from":[214],"7":[215],"6":[219],"patients.":[221],"showed":[224],"that":[225],"CD4+":[233,248],"CD8+":[235],"lymphocytes":[236,240],"also":[238],"increased":[239],"expressing":[241],"activation":[243],"marker":[244],"CD69":[245],"both":[247],"(2\u20135x)":[249],"CD4\u2212":[251],"populations":[252],"(\u223c":[253],"3x).":[254],"Conclusion:":[255],"a":[257],"compound":[258],"used":[259],"leishmaniasis,":[264],"can":[265],"interact":[266],"activate":[272],"donors.":[282],"Results":[283],"further":[285],"rationale,":[286],"addition":[288],"mouse":[291],"tumor":[292],"data,":[293],"proof":[295],"concept":[297],"trials":[299],"effecting":[301],"augmentation":[302],"through":[305],"inhibition":[306],"phosphatases.":[311],"No":[312],"significant":[313],"financial":[314],"relationships":[315],"disclose.":[317]},"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2017-04-07T00:00:00"}